Know Cancer

or
forgot password


N/A
18 Years
N/A
Open (Enrolling)
Both
Non Small Cell Lung Cancer

Thank you

Trial Information


Inclusion Criteria:



1. Patients with a diagnosis of either metastatic NSCLC or metastatic CRC are eligible.

2. Patients should be due to undergo palliative chemotherapy as part of their standard
clinical care.

3. Patients must be able to receive and understand verbal and written information
regarding the study and give written, informed consent.

Exclusion Criteria:

1. Persons under 18 years of age.

2. Conditions in which research blood sampling may increase risk of complications for
the patient and/or the investigators. For example, uncontrolled bleeding, patients
with a known blood-borne viral infection (eg. hepatitis B or C, HIV) or poor venous
access.

3. Other persons in whom clinical judgement by the investigator concluded that the
patient should not participate in the study. For example, anticipated poor compliance
to attend for follow-up.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Establish whether CTCs are detectable using novel CMOS technology in patients with metastatic cancer.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Ying Kiat Zee, MBBS, MRCP

Investigator Role:

Principal Investigator

Investigator Affiliation:

National University Hospital, Singapore

Authority:

Singapore: Domain Specific Review Boards

Study ID:

Version 1

NCT ID:

NCT01596452

Start Date:

June 2012

Completion Date:

Related Keywords:

  • Non Small Cell Lung Cancer
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Neoplastic Cells, Circulating

Name

Location